GPT HEALTHCARE LIMITED
GPTHEALTH · Capital Goods · NSE
₹150
Current Market Price
Fair Value (DCF)
₹207
Discount to FV
+38.1%
Updated just now
YieldIQ Score
50/100
Piotroski F-Score
5/9
Economic Moat
Moderate
Confidence
48%
ROE
15.7%
Debt/Equity
0.34
WACC
11.1%
Market Cap
₹1,231 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
25.0%
Return on capital employed
EV / EBITDA
14.1×
Enterprise multiple
Debt / EBITDA
1.1×
Leverage vs earnings
Interest Coverage
28.4×
EBIT covers interest
Current Ratio
1.06×
Short-term liquidity
Asset Turnover
1.23×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹149.98
Bear case
Discount -16.9%
Base case
Discount +27.6%
Bull case
Discount +44.3%
Ratio Trends
GPTHEALTH · last 5 annual periods
ROE
15.7%
ROCE
25.0%
Operating Margin
—
Debt / Equity
0.34×
PE
—
EV / EBITDA
—
Historical Financials
GPTHEALTH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹337 Cr | ₹360 Cr | ₹400 Cr | ₹407 Cr | ₹473 Cr | +8.8% |
| EBITDA | ₹77.9 Cr | ₹79.3 Cr | ₹92.5 Cr | ₹91.8 Cr | ₹90.1 Cr | +3.7% |
| EBIT | — | — | ₹75.1 Cr | — | — | +0.0% |
| PAT | ₹41.7 Cr | ₹39.0 Cr | ₹47.8 Cr | ₹49.9 Cr | ₹42.2 Cr | +0.3% |
| EPS (diluted) | — | — | ₹5.96 | — | — | +0.0% |
| CFO | ₹66.0 Cr | ₹66.4 Cr | ₹68.8 Cr | ₹67.4 Cr | ₹81.2 Cr | +5.3% |
| CapEx | ₹-10.6 Cr | ₹-9.9 Cr | ₹-19.4 Cr | ₹-49.9 Cr | ₹-41.8 Cr | — |
| FCF | ₹55.4 Cr | ₹56.4 Cr | ₹49.4 Cr | ₹17.5 Cr | ₹39.3 Cr | -8.2% |
| Total Assets | ₹323 Cr | ₹327 Cr | ₹346 Cr | ₹384 Cr | ₹465 Cr | +9.5% |
| Total Debt | ₹102 Cr | ₹82.4 Cr | ₹30.5 Cr | ₹35.3 Cr | ₹91.2 Cr | -2.7% |
| Shareholders' Equity | ₹158 Cr | ₹165 Cr | ₹218 Cr | ₹248 Cr | ₹269 Cr | +14.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
GPTHEALTH vs 2 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 SHALBY SHALBY | — | — | Pending | 0.6% | — |
INDRAMEDCO INDRAMEDCO | — | — | Pending | 24.8% | 18.6× |
Click a ticker to view its fair-value analysis.
Dividend History
5 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹6.00/sh
Last payout
2025-11-14
₹1.00
Peak payout
₹1.50
Trailing yield
1.67%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. GPT HEALTHCARE LIMITED (GPTHEALTH.NS) trades at 149.98 vs a model fair value of 207.05, a gap of 38.1%. Piotroski F-score: 5/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of GPTHEALTH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for GPTHEALTH →
Compare
Head-to-head with peers
Compare GPTHEALTH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse GPTHEALTHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.